16 May 2023 : Original article
Breaking Antimicrobial Resistance: High-Dose Amoxicillin with Clavulanic Acid for Urinary Tract Infections Due to Extended-Spectrum Beta-Lactamase (ESBL)-Producing Klebsiella pneumoniae
Piotr Wilkowski1ABCDEF, Ewa HryniewieckaDOI: 10.12659/AOT.939258
Ann Transplant 2023; 28:e939258
Table 3 Antibiotic susceptibility of K. pneumoniae strains in urine cultures.
| Case No | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 |
|---|---|---|---|---|---|---|---|---|---|
| Amikacin | S≤2 | S≤2 | I=4 | S≤2 | S≤2 | S≤2 | S≤2 | I=16 | I=16 |
| Amoxicillin/Clavulanate | I=8 | R=16 | R≥32 | R≥32 | R≥32 | R≥32 | R≥32 | S=8 | R≥32 |
| Ampicillin | R≥32 | R≥32 | R≥32 | R≥32 | nd | R≥32 | R ≥32 | R≥32 | R≥32 |
| Cefalexin | R≥64 | R≥64 | R≥64 | R≥64 | R≥32 | R≥64 | R≥64 | R≥64 | R≥64 |
| Cefepime | R=16 | R≥32 | R≥32 | R≥32 | R≥16 | R≥32 | R≥32 | R≥32 | R≥32 |
| Cefotaxime | R≥64 | R≥64 | R≥64 | R≥64 | R≥32 | R≥64 | R≥64 | R≥64 | R≥64 |
| Ceftazidime | R≥64 | R=32 | R≥64 | R=32 | R=32 | R=32 | R=32 | R≥64 | R≥64 |
| Cefuroxime | nd | R≥64 | R≥64 | R≥64 | R≥32 | R≥64 | R≥64 | R≥64 | R≥64 |
| Cefuroxime axetil | R≥64 | R≥64 | R≥64 | R≥64 | nd | R≥64 | R≥64 | R≥64 | R≥64 |
| Ceftriaxone | nd | R | R | R | nd | R | R | R | R |
| Ciprofloxacin | R≥4 | R=1 | R≥4 | R≥4 | R≥2 | R=2 | R≥4 | R≥4 | R≥4 |
| Ertapenem | S≤0,5 | S≤0.12 | S≤0.12 | S≤0.12 | S≤0.12 | S≤0.12 | S≤0.12 | S≤0.12 | S≤0.12 |
| Gentamicin | R≥16 | S≤1 | S≤1 | S≤1 | S≤1 | S≤1 | S≤1 | R≥16 | R≥16 |
| Imipenem | S≤0.25 | S | S | S | S≤0.25 | S | S | S | S |
| Meropenem | S | S≤0.25 | S≤0.25 | S≤0.25 | S≤0.25 | S≤0.25 | S≤0.25 | S≤0.25 | S≤0.25 |
| Norfloxacin | R≥16 | R=2 | R≥4 | R≥16 | R≥16 | R=4 | R≥16 | R≥16 | R≥16 |
| Piperacillin/Tazobactam | R≥128 | I=16 | R≥128 | R≥32 | R=32 | I=16 | R=32 | R≥32 | R≥128 |
| Trimethoprim/Sulfamethoxazole | R≥320 | R≥320 | R≥320 | R≥320 | R≥16 | R≥320 | R≥320 | R=160 | S≤20 |
| S – susceptible; I – intermediate susceptibility; R – resistant; nd – no data. | |||||||||






